Hepion Pharmaceuticals, Inc. (HEPA) Executive Compensation
Hepion Pharmaceuticals, Inc. (HEPA) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: HEPA
CIK: 1583771
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grassi & Co., CPAs, P.C.
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerLouis Pizzileo
Audit LocationJericho, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-02 | 2026-09-29 | 4 | 0001493152-26-045526 | View SEC Doc Filr Page |
| 8-K | 2026-10-02 | 2026-10-01 | 8-K | 0001493152-26-045447 | View SEC Doc Filr Page |
| 8-K | 2026-09-28 | 2026-09-21 | 8-K | 0001493152-26-044432 | View SEC Doc Filr Page |
| 3 | 2026-09-16 | 2026-08-03 | 3 | 0001493152-26-042909 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-16 | — | SCHEDULE 13D/A Filing | 0001493152-26-042907 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-15 | — | SCHEDULE 13G Filing | 0001493152-26-042788 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-03 | 4 | 0001493152-26-042470 | View SEC Doc Filr Page |
| DEF 14C | 2026-09-10 | 2026-09-10 | DEF 14C | 0001493152-26-042187 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-08-19 | 4 | 0001493152-26-042169 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-03 | 8-K | 0001493152-26-041801 | View SEC Doc Filr Page |
| PRE 14C | 2026-08-31 | 2026-08-28 | PRE 14C | 0001493152-26-040669 | View SEC Doc Filr Page |
| 8-K | 2026-08-27 | 2026-08-25 | 8-K | 0001493152-26-040411 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | 4 | 0001493152-26-039705 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | 4 | 0001493152-26-039702 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | 4 | 0001493152-26-039701 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | 4 | 0001493152-26-039698 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | 4 | 0001493152-26-039690 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | 4 | 0001493152-26-039688 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | 4 | 0001493152-26-039685 | View SEC Doc Filr Page |
| 3 | 2026-08-21 | 2026-08-19 | 3 | 0001493152-26-039550 | View SEC Doc Filr Page |
| 8-K | 2026-08-20 | 2026-08-19 | 8-K | 0001493152-26-039488 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-20 | — | SCHEDULE 13D/A Filing | 0001493152-26-039484 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-08-20 | — | SCHEDULE 13D Filing | 0001493152-26-039483 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-08-20 | — | SCHEDULE 13D Filing | 0001493152-26-039482 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001493152-26-037562 | View SEC Doc Filr Page |